Posted by ABMN Staff on May 13th, 2024
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Stock analysts at B. Riley lifted their Q2 2024 earnings per share estimates for shares of Cytokinetics in a research note issued on Thursday, May 9th. B. Riley...
More of this article »